BioCentury
ARTICLE | Company News

Valeant Pharmaceuticals International deal

April 26, 2010 7:00 AM UTC

Valeant signed a binding agreement to acquire an undisclosed private Brazilian generics and OTC company for about BRL97 million ($56 million). According to Valeant, the company reported 2009 sales of ...